SANOFI CHIMIE

SANOFI CHIMIE in India operates as a manufacturing entity, specifically a factory. It is involved in the production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates.

Company Introduction:

Sanofi Chimie is a division within the global pharmaceutical giant Sanofi, dedicated to the chemical manufacturing aspects, primarily the production of Active Pharmaceutical Ingredients (APIs) and intermediates. In India, Sanofi has a significant presence, and facilities under the "Sanofi Chimie" umbrella function as manufacturing plants.

These facilities are integral to Sanofi's global supply chain, producing critical components for various pharmaceutical formulations. They adhere to stringent international quality standards (GMP) to ensure the safety and efficacy of their products. Sanofi's operations in India encompass manufacturing, research and development, and commercial activities, contributing significantly to the country's pharmaceutical landscape and serving both domestic and international markets.

Nature of Business: Factory (Manufacturer)

Lantus (Insulin Glargine)

Toujeo (Insulin Glargine)

Apidra (Insulin Glulisine)

Amaryl (Glimepiride)

Cardace (Ramipril)

Plavix (Clopidogrel)

Clexane (Enoxaparin)

Frisium (Clobazam)

Combiflam (Ibuprofen and Paracetamol)

Enterogermina (Bacillus clausii spores)

FluQuadri (Quadrivalent Influenza Vaccine)

Hexaxim (DTaP-IPV-Hib-HepB vaccine)

Adacel (Tdap vaccine)

Myozyme (Alglucosidase alfa)

Cerezyme (Imiglucerase)

Fabrazyme (Agalsidase beta)